Parkinson's disease was first described as a distinct condition in 1817
James Parkinson, a British physician, published the first medical account of what we now call Parkinson's disease. In his 1817 essay titled "An Essay on the Shaking Palsy," he described six patients with a condition marked by tremor, muscle stiffness, and a forward-leaning posture. Parkinson called it "shaking palsy" because the most visible symptom was an involuntary shaking of the limbs. His careful observations laid the foundation for how doctors recognize and diagnose the disease today.
Before Parkinson's formal description, physicians had observed similar symptoms in patients for centuries, but they did not understand these symptoms as a single disease. Some cases were attributed to aging, others to different conditions entirely. Parkinson's work changed that by showing that these symptoms clustered together in a recognizable pattern.
Key Takeaways
- James Parkinson identified the disease in 1817 and named it "shaking palsy" based on its most obvious symptom.
- Doctors had observed similar symptoms for centuries before Parkinson, but did not recognize them as one condition.
- In the late 1800s, French neurologist Jean-Martin Charcot expanded understanding of the disease and gave it the name "Parkinson's disease."
- The discovery of dopamine's role in the brain in the 1950s transformed how doctors treat the disease.
- Modern research continues to uncover what causes Parkinson's and how to slow its progression.
How doctors understood Parkinson's disease before 1817
Ancient Greek and Roman physicians documented cases of tremor and muscle rigidity in their medical texts, though they did not connect these symptoms to a single underlying cause. Medieval and Renaissance doctors continued to observe patients with similar problems but often attributed them to separate ailments—some blamed the shaking on nerve damage, others on imbalances in the body's humors, the theory that dominated medicine at the time.
By the 1700s, as medical knowledge advanced, physicians began to notice that certain patients showed the same combination of symptoms: shaking that worsened at rest, stiffness that made movement difficult, and a distinctive posture with the body bent forward. However, without a framework to understand what caused these symptoms, doctors treated each one separately rather than recognizing them as parts of one disease.
Jean-Martin Charcot and the naming of Parkinson's disease
In the 1870s and 1880s, French neurologist Jean-Martin Charcot studied James Parkinson's original observations and added his own detailed research. Charcot identified additional symptoms that Parkinson had not emphasized, including rigidity (stiffness that persists even when the person tries to relax) and what he called the "pill-rolling" tremor—a shaking of the fingers that resembles rolling a small pill between the thumb and forefinger. Charcot's work was more systematic and reached a wider medical audience.
Charcot renamed the condition "Parkinson's disease" in honor of James Parkinson's pioneering work. This name stuck and is still used today. Charcot's contributions were so significant that he is often credited with establishing Parkinson's disease as a distinct neurological disorder that doctors could diagnose and study.
The discovery of dopamine and modern treatment
For more than a century after Charcot, doctors could describe Parkinson's disease and recognize its symptoms, but they did not know what caused it or how to treat it effectively. That changed in the 1950s when researchers discovered that the brains of people with Parkinson's disease had lower levels of a chemical messenger called dopamine. This discovery explained why the disease caused movement problems—dopamine is essential for smooth, controlled movement.
In 1967, a medication called levodopa (or L-DOPA) was approved for treating Parkinson's disease. Levodopa works by increasing dopamine levels in the brain, which reduces tremor, stiffness, and slowness of movement. This was the first treatment that actually addressed the underlying problem rather than just masking symptoms. Levodopa remains one of the most effective medications for Parkinson's disease today, though doctors now use it alongside other drugs and therapies.
What researchers have learned since the 1960s
Since the dopamine discovery, scientists have identified other brain chemicals involved in Parkinson's disease and developed medications that work on these different systems. Researchers have also found that Parkinson's involves changes in a protein called alpha-synuclein, which accumulates in brain cells and damages them over time. This finding has opened new directions for research into how to slow or stop the disease's progression.
Modern neuroimaging—brain scans that can show changes in the brain—has made it possible to diagnose Parkinson's disease more accurately and earlier than was possible in Parkinson's or Charcot's time. Genetic studies have revealed that some forms of Parkinson's disease run in families, though most cases appear to result from a combination of genetic and environmental factors. Deep brain stimulation, a surgical procedure that uses electrical impulses to regulate brain activity, has become an option for people whose symptoms are not well controlled by medication alone.
Why the history of Parkinson's discovery matters today
Understanding how Parkinson's disease was discovered and how knowledge about it has grown helps explain why current treatments work the way they do and why research is still ongoing. The disease took more than 150 years to move from a description of symptoms to an understanding of its cause. This history shows that even well-known diseases can hold mysteries that take decades to solve.
For someone newly diagnosed with Parkinson's disease, knowing this history can provide perspective: the treatments available today are far more effective than anything available to patients even 50 years ago, and research into new treatments continues. The same careful observation that James Parkinson used in 1817 remains central to how doctors study the disease and develop better ways to manage it.
Frequently Asked Questions
Did James Parkinson have Parkinson's disease himself?
There is no historical evidence that James Parkinson had the disease. He was a physician and apothecary who observed patients with the condition and documented what he saw. He remained active in his medical practice and other work throughout his life.
Why did it take so long to understand what causes Parkinson's disease?
The brain is complex, and the technology to study it in detail did not exist until the 20th century. Researchers needed microscopes, chemical analysis, and brain imaging to discover dopamine's role. Even today, scientists are still uncovering new aspects of how the disease develops.
Has Parkinson's disease always been the same, or has it changed over time?
The disease itself has not changed, but our understanding of it has. People in ancient times likely had Parkinson's disease, but doctors called it by different names or confused it with other conditions. The symptoms and progression are the same as they were in 1817.
Are there any treatments that came from studying Parkinson's disease history?
Yes. Understanding that dopamine was low in Parkinson's brains led directly to levodopa treatment. Studying how the disease progresses helped doctors develop other medications and therapies. Historical case studies also help doctors recognize early signs of the disease in new patients.